BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, July 19, 2026
Breaking News: New research identifies EBV antigen targets for MS therapiesBreaking News: Science fiction realized: BCI tech is here
Home » Topics » BioWorld Asia

BioWorld Asia
BioWorld Asia RSS Feed RSS

Oral cholera vaccine could boost global control efforts: study

July 15, 2015
By John Fox
HONG KONG — An oral cholera vaccine has been shown to be safe and protective against severe disease in children and adults in urban Bangladesh where the disease is endemic, supporting its use in mass immunization programs, according to the first real-life trial of the new Shanchol vaccine.
Read More

New CFDA regs covering surprise inspections effective on Sept. 1

July 15, 2015
By Cornelia Zou
HONG KONG – Regulators in China will start making unannounced inspections at pharmaceutical and medical device companies.
Read More

WHO raps another Indian CRO on data integrity

July 15, 2015
By T.V. Padma
NEW DELHI – The WHO has rapped yet another Indian clinical research organization (CRO) for "critical lapses and major deviations" during the conduct of clinical trials, bringing the spotlight back to the need for Indian pharma firms and CROs to pull up their socks over stringent adherence to trial protocols.
Read More

Data integrity issues in India pharma industry: E&Y survey finds

July 15, 2015
By T.V. Padma
NEW DELHI – The Indian pharma industry is struggling with data integrity issues that repeatedly crop up during inspections by global regulators; they are tarnishing the industry's reputation while undermining global confidence in Indian products.
Read More

Other news to note

July 15, 2015
Oramed Pharmaceuticals Inc., of Jerusalem, signed a nonbinding letter of intent for an investment and license agreement in China with Sinopharm Capital Management Co. Ltd. and Hefei Life Science & Technology Park Investments and Development Co. Ltd.
Read More

China's start-up board: Promise for biotechs but stock crisis needs taming

July 15, 2015
By Shannon Ellis
SHANGHAI – China's stock market collapse over the past week has been on everyone's minds. Eyes have been glued to cell phone apps with greater concentration than ever before, checking minute to minute how fast and how far share prices will fall.
Read More

Mild market rebound, but China's public firms still suffering losses

July 14, 2015
By Cornelia Zou
HONG KONG – A dramatic plummeting in the value of publicly listed shares in Mainland China over the last month has wiped out roughly $3 trillion in wealth and raised fears of a collapse in the country's stock market, a collapse that could exacerbate slowing economic growth.
Read More

Thalidomide derivative key to new antileukemic therapies, study shows

July 8, 2015
By John Fox
HONG KONG – The mechanism by which the thalidomide derivative lenalidomide treats a type of myelodysplastic syndrome (MDS) has been elucidated, reported in the July 1, 2015, edition of Nature, could aid the development of new therapies for leukemias and other malignancies.
Read More

Shenogen seeks to move 'traditional' medicine into cancer mainstream

July 8, 2015
By Marie Powers
Jun Bao, senior vice president and chief business officer of Shenogen Pharma Group, begins nearly every presentation about the company with a slide that features strikingly different images. At the top is a simple photo of the ubiquitous Epimedium wushanense, commonly known as horny goat weed, a hardy perennial that grows mainly in China and has been widely used in traditional Chinese medicine (TCM) as an aphrodisiac and a treatment for erectile dysfunction. Shenogen's lead molecule, icaritin, is derived from the plant.
Read More

U.S. maintains leadership, but New Zealand vaults to third place in the global biotech rankings

July 8, 2015
By Peter Winter
The latest Scientific American Worldview Scorecard, released at the recent BIO 2015 International Convention, which ranks the biotechnology innovation potential of 54 countries, finds that the U.S. is the leading country once again based on its performance in seven categories used in the study, with Denmark and three Asia-Pacific countries – New Zealand, Australia and Singapore – rounding out the top five.
Read More
Previous 1 2 … 663 664 665 666 667 668 669 670 671 … 1495 1496 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 17, 2026.
  • ALN-5288 lowers tau levels in preclinical models

    BioWorld Science
    Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
  • Elderly hands holding broken brain structure

    Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability

    BioWorld Science
    Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
  • International currency symbols

    Capital remains selective in ‘barbell’ biotech market

    BioWorld
    Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
  • Brush scrubbing brain figurine with soap

    PSB-229 reduces plaque burden in Alzheimer’s models

    BioWorld Science
    Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing